<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.phyplu.2021.100212"><dct:format>application/xml</dct:format><dct:title>Cytotoxic activity of crude extracts and fractions of African peach (nauclea latifolia smith) stem bark on two cancer cell lines</dct:title><dct:creator>Oluwakemi Charles-Okhe</dct:creator><dct:creator>Michael A. Odeniyi</dct:creator><dct:creator>Titilayo O. Fakeye</dct:creator><dct:creator>Omonike O. Ogbole</dct:creator><dct:creator>Toluwanimi E. Akinleye</dct:creator><dct:creator>Adekunle J. Adeniji</dct:creator><dct:subject><rdf:Bag><rdf:li>African peach (nauclea latifolia)</rdf:li><rdf:li>Phytochemicals</rdf:li><rdf:li>Anticancer</rdf:li><rdf:li>MCF-7</rdf:li><rdf:li>RD</rdf:li></rdf:Bag></dct:subject><dct:description>Phytomedicine Plus 2 (2022). doi:10.1016/j.phyplu.2021.100212</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Phytomedicine Plus</prism:publicationName><prism:copyright>&#169; 2021 The Author(s). Published by Elsevier B.V.</prism:copyright><dct:publisher>Elsevier B.V.</dct:publisher><prism:issn>2667-0313</prism:issn><prism:volume>2</prism:volume><prism:number>1</prism:number><prism:coverDisplayDate>February 2022</prism:coverDisplayDate><prism:doi>10.1016/j.phyplu.2021.100212</prism:doi><prism:url>http://dx.doi.org/10.1016/j.phyplu.2021.100212</prism:url><dct:identifier>doi:10.1016/j.phyplu.2021.100212</dct:identifier><bam:articleNumber>100212</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-12-27T12:11:02Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="fla" version="5.6" xml:lang="en"><ja:item-info><ja:jid>PHYPLU</ja:jid><ja:aid>100212</ja:aid><ce:article-number>100212</ce:article-number><ce:pii>S2667-0313(21)00194-9</ce:pii><ce:doi>10.1016/j.phyplu.2021.100212</ce:doi><ce:copyright type="other" year="2021">The Author(s)</ce:copyright></ja:item-info><ja:head><ce:title id="tte0002">Cytotoxic activity of crude extracts and fractions of African peach (nauclea latifolia smith) stem bark on two cancer cell lines</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2667031321001949-0849eec54446c300ebf477ab1ca5ed46"><ce:given-name>Oluwakemi</ce:given-name><ce:surname>Charles-Okhe</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0002" author-id="S2667031321001949-f28b1f77cfa85a5350668741560746a9"><ce:given-name>Michael A.</ce:given-name><ce:surname>Odeniyi</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:deleodeniyi@gmail.com">deleodeniyi@gmail.com</ce:e-address></ce:author><ce:author id="au0003" author-id="S2667031321001949-46d19f1e8c40173ed0f033f21b232346"><ce:given-name>Titilayo O.</ce:given-name><ce:surname>Fakeye</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S2667031321001949-e19dca43f3944cc94dd97cada675ab76"><ce:given-name>Omonike O.</ce:given-name><ce:surname>Ogbole</ce:surname><ce:cross-ref refid="aff0003"><ce:sup loc="post">c</ce:sup></ce:cross-ref></ce:author><ce:author id="au0005" author-id="S2667031321001949-b4947a18982e25e0e43fb4dec276da29"><ce:given-name>Toluwanimi E.</ce:given-name><ce:surname>Akinleye</ce:surname><ce:cross-ref refid="aff0003"><ce:sup loc="post">c</ce:sup></ce:cross-ref></ce:author><ce:author id="au0006" author-id="S2667031321001949-58fc2287cce4aa1f318a319c51bc94da"><ce:given-name>Adekunle J.</ce:given-name><ce:surname>Adeniji</ce:surname><ce:cross-ref refid="aff0004"><ce:sup loc="post">d</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff0001" affiliation-id="S2667031321001949-2d719fb0beecee5961963ee130c2f2e0"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Department of Pharmaceutics and Industrial Pharmacy, University of Ibadan, Oyo State, Nigeria</ce:textfn><sa:affiliation><sa:organization>Department of Pharmaceutics and Industrial Pharmacy</sa:organization><sa:organization>University of Ibadan</sa:organization><sa:state>Oyo State</sa:state><sa:country>Nigeria</sa:country></sa:affiliation><ce:source-text id="staff0001">aDepartment of Pharmaceutics and Industrial Pharmacy, University of Ibadan, Oyo State, Nigeria</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2667031321001949-a43288ad7c793f0250def8cc65b51c8b"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Department of Clinical Pharmacy and Pharmacy Administration, University of Ibadan, Oyo State, Nigeria</ce:textfn><sa:affiliation><sa:organization>Department of Clinical Pharmacy and Pharmacy Administration</sa:organization><sa:organization>University of Ibadan</sa:organization><sa:state>Oyo State</sa:state><sa:country>Nigeria</sa:country></sa:affiliation><ce:source-text id="staff0002">bDepartment of Clinical Pharmacy and Pharmacy Administration, University of Ibadan, Oyo State, Nigeria</ce:source-text></ce:affiliation><ce:affiliation id="aff0003" affiliation-id="S2667031321001949-e8c92c97a51624c044783570460e7664"><ce:label>c</ce:label><ce:textfn id="cetextfn0003">Department of Pharmacognosy, University of Ibadan, Ibadan, Nigeria</ce:textfn><sa:affiliation><sa:organization>Department of Pharmacognosy</sa:organization><sa:organization>University of Ibadan</sa:organization><sa:city>Ibadan</sa:city><sa:country>Nigeria</sa:country></sa:affiliation><ce:source-text id="staff0003">cDepartment of Pharmacognosy, University of Ibadan, Ibadan, Nigeria</ce:source-text></ce:affiliation><ce:affiliation id="aff0004" affiliation-id="S2667031321001949-b92ac0a2f6ea4a2fb1b566f6febabab7"><ce:label>d</ce:label><ce:textfn id="cetextfn0004">Department of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria</ce:textfn><sa:affiliation><sa:organization>Department of Virology, College of Medicine</sa:organization><sa:organization>University of Ibadan</sa:organization><sa:city>Ibadan</sa:city><sa:country>Nigeria</sa:country></sa:affiliation><ce:source-text id="staff0004">dDepartment of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author.</ce:text></ce:correspondence></ce:author-group><ce:date-received day="21" month="10" year="2021"/><ce:date-revised day="22" month="12" year="2021"/><ce:date-accepted day="27" month="12" year="2021"/><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" role="background" view="all"><ce:section-title id="cesectitle0002">Background</ce:section-title><ce:simple-para id="spara011" view="all">The purpose of this research work is to investigate and establish the anticancer (cytotoxic) properties of African peach (Nauclea latifolia) stem bark extract and fractions on breast cancer cell lines (MCF-7), skeletal muscle cancer (RD) cell lines and to determine the selectivity index (SI) on normal African green monkey kidney cell lines (Vero).</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0002" role="materials-methods" view="all"><ce:section-title id="cesectitle0003">Materials and Methods</ce:section-title><ce:simple-para id="spara012" view="all">Crude extract and fractions obtained from acid-base fractionation and vacuum liquid chromatography (VLC) using graded concentrations of hexane, methanol, ethyl-acetate to obtain sample A to G. These samples were tested against standard cancer cell lines (MCF-7 &#x2013;breast cancer; RD cells- skeletal muscle cancer) and normal Vero cell lines to determine the cytotoxicity based on the IC<ce:inf loc="post">50</ce:inf> generated. The anticancer activity was evaluated using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide colorimetric assay against two cancer cell lines at six different concentrations from 0.01 to 1000&#160;&#181;g/mL. The data generated were analyzed with Graph Pad prism 5 to obtain the IC<ce:inf loc="post">50</ce:inf>.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0003" role="results" view="all"><ce:section-title id="cesectitle0004">Results</ce:section-title><ce:simple-para id="spara013" view="all">Sample C- neutral fraction gave IC<ce:inf loc="post">50</ce:inf> values of 3.23&#160;&#181;g/mL and 13.15&#160;&#181;g/mL for MCF-7 and RD respectively. Sample <ce:small-caps>D</ce:small-caps>- Hexane/ethyl acetate fraction 50:50 gave IC<ce:inf loc="post">50</ce:inf> values of 16.70&#160;&#181;g/mL and 8.97&#160;&#181;g/mL for MCF-7 and RD respectively. Sample B- basic fraction had IC<ce:inf loc="post">50</ce:inf> of 20.51&#160;&#181;g/mL and 16.96&#160;&#181;g/mL for MCF-7 and RD respectively. Sample G- Methanol fraction had IC<ce:inf loc="post">50</ce:inf> of 28.56&#160;&#181;g/mL and 22.52&#160;&#181;g/mL for MCF-7 and RD respectively. These four samples exhibited significant anticancer activities on the MCF-7 and RD cancer cell lines. These values are comparable to that of vincristine used as standard anticancer drug with IC<ce:inf loc="post">50</ce:inf> of 0. 82&#160;&#181;g/mL and 6.31&#160;&#181;g/mL for MCF-7 and RD cell lines respectively. The selectivity index (SI) of three samples was carried out using Vero cell line and sample C - neutral fraction had the best selectivity against the cancer cell lines under investigation.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0004" role="conclusion" view="all"><ce:section-title id="cesectitle0005">Conclusions</ce:section-title><ce:simple-para id="spara014" view="all"><ce:italic>Nauclea latifolia</ce:italic> fractions have profound cytotoxic activities when tested in vitro on standard cancer cell lines and could be considered as a potential chemotherapeutic agent.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0006">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">African peach (nauclea latifolia)</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Phytochemicals</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Anticancer</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">MCF-7</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">RD</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
